Fundraising FoxEos Advisory
Impact investorSt Andrews · Seed–Growth · 7 people tracked
Also known as Kinburn (209) Llp
Find your way into Eos Advisory
Sign up to find every way you can get introduced to Eos Advisory
- Your email: who you already know at Eos Advisory, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eos Advisory team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Eos acts as a link between non-specialist investors and science- and technology-intensive companies. Its portfolio spans quality of life and environmental sustainability, covering disease diagnostics, prevention and treatment, food and water security, pollution reduction, clean energy and sustainable infrastructure. The firm seeks commensurate financial returns from early-stage patient capital while backing businesses that generate positive impact. Eos works in long-term partnerships with family offices, individuals, companies and institutional investors, operating across seed and growth stages on a managed or discretionary basis, from multistage multiyear relationships to angel syndicates. It offers S/EIS UK tax relief to eligible investors when available and is committed to diversity and inclusion.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website
What they invest in
from 23 of 25 portfolio companiesHealthtech ×15Biotech ×12Medical Devices ×12Deep Tech ×8AI & Machine Learning ×5Cleantech ×5Digital Health ×4Hardware ×4
HQs:United Kingdom×15Italy×1United States×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×32 founders×13 founders×24+ founders×2
Investments · 25 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 42023 · 211 dated
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsScottish EnterpriseAlba EquityBritish Business BankMaven Capital Partners
TaiSan develops sodium batteries and works with operators, OEMs and research institutions to deploy them into vehicle fleets.
Advanced ManufacturingCleantechEnergyHardwareNew Materials
Co-investorsAdelineEIT InnoEnergyAFI VenturesMercia VenturesTSP VenturesHeartfelt Capital+1 more
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to more patients.
Digital HealthMedical DevicesRobotics
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to patients recovering from mobility issues such as stroke.
Digital HealthMedical DevicesRoboticsEdinburgh, GB
Rowan Armstrong(Founder)inShea Quinn(Founder)in
Co-investorsBallad VenturesScottish National Investment BankConduit ConnectOld College Capital
Biotangents develops AmpliSpec, a LAMP-based molecular diagnostics platform for veterinary use that delivers pathogen-specific results in under two hours at the point of care, in laboratories, or embedded within partner systems.
AgTechBiotechMedical Devices
Co-investorsInvesting Women AngelsKelvin Capital
CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss.
BiotechDeep TechHealthtechCambridge, GB
Arpan Desai(CEO & Co-founder)inPrashant Shah(Co-founder)Sunil Shah(Co-founder)
Co-investorsCambridge Angels groupFuture Planet CapitalUK Innovation & Science Seed Fund
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankGabriel Investment SyndicateInvesting Women AngelsInvestment Fund for Scotland+4 more
Carcinotech develops tumor models and assay solutions to improve preclinical drug development for cancer therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesScotland, GB
Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)Lorna(Chief Scientific Officer)Susanne
Chemify builds automated chemical synthesis systems combining chemistry, AI, and robotics to digitize molecular design and manufacturing.
AI & Machine LearningBiotechDeep TechGlasgow, GB
Lee Cronin(Founder)in
Co-investorsBlueYard CapitalInsight PartnersHAWKTAILHorizons VenturesLauder PartnersPossible Ventures+5 more
The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.
Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US
Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)in
Co-investorsMaven Capital PartnersOld College CapitalScottish Enterprise
Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies.
AI & Machine LearningBiotechHealthtechEdinburgh, GB
Jessica Birt(Co-founder & CEO)inMatthew Dale(Co-founder & CSO)in
Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions.
BiotechHealthtechLongevityMedical Devices
Catherine(CEO)Clare Wareing(CEO)in
Co-investorsAlba EquityApollo Informal InvestmentScottish National Investment BankScottish Enterprise
ENOUGH produces sustainable food ingredients and works with customers, suppliers, and partners toward its mission.
FoodTechImpact & Social Good
Co-investorsDCVC (Data Collective)
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration.
BiotechCleantechDeep TechHealthtechMedical Devices
Asel Sartbaeva(Co-Founder & CEO)inMatt Slade(Co-Founder & Chief of Staff)inStephen Wells(Co-Founder & Advisor)Aswin Doekhie(Co-Founder & CTO)inSabine Ficek(CFO)inSimon Bennett(Chief Commercial Officer)
Co-investorsCalculus Capital Ltd.Elbow Beach CapitalEmpirical VenturesHERmesa
GM Flow provides flow measurement solutions for oil and gas operations.
CleantechEnergyHardwareIoTAberdeen, GB
GavinVictorChrisIqbal
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform.
BiotechDeep TechHealthtechMedical DevicesGlasgow, GB
Owain Millington(Chief Executive Officer)in
Co-investorsMedical Incubator Japan K.K.
Laverock Tx is a biotechnology company working in the gene therapy and gene editing space, with a leadership and advisory team drawn from cell and gene therapy, immunology, and life-science investing backgrounds.
BiotechDeep TechHealthtech
Co-investorsCalculus Capital Ltd.Future Planet CapitalTekfen VenturesUK Innovation & Science Seed Fund
Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains.
HealthtechMedical DevicesRoboticsGlasgow, GB
Nico Fenu(Co-Founder & Chief Operating Officer)inREBECCA CLEARY(Executive Officer, Director)inNICOLA GIUSEPPE FENU(Executive Officer, Director)Rebecca Cleary(Co-Founder & Chief Technical Officer)inNikki Palfrey(Chief Executive Officer)inALBERT NICHOLL(Director)in
Co-investorsMaven Capital PartnersScottish Enterprise
Naturbeads develops biodegradable cellulose microspheres to replace microplastics in consumer products such as cosmetics and paints.
Circular EconomyCleantechNew MaterialsItaly, IT
Janet Scott(Co-founder)Davide Mattia(Co-founder)inGiovanna Laudisio(Co-founder)in
Co-investorsInnovate UKCDP Venture CapitalMI.TO TechnologyRegeneration.VC
Neupulse develops a wearable device that delivers drug-free, non-invasive neurostimulation to support everyday wellbeing and relaxation, based on neuroscience research.
HardwareHealthtechWellness & Fitness
Co-investorsMercia VenturesMidlands Engine Investment Fund II
SenseBP is a wearable blood pressure monitoring device that eliminates the need for traditional pressure cuffs.
HardwareHealthtech
Co-investorsInvesting Women AngelsKelvin CapitalForesightGabriel Investments
SILVERbac is a patented antimicrobial textile technology that permanently incorporates pure silver particles into fibres, making the treatment non-leaching, non-toxic, and eco-friendly.
Advanced ManufacturingCleantechHealthtechNew MaterialsDubai, GB
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Co-investorsIQ CapitalMercia VenturesOld College Capital
.jpeg){kind=logo}
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Novel TechnologiesPenrhosbio
Portfolio news
latest coverage across their companiesTaiSan · techfundingnews.com · Jul 6, 2026
Naturbeads · trysignalbase.com · Apr 25, 2026
Bioliberty · finsmes.com · Mar 23, 2026
Neupulse · neupulse.co · Feb 19, 2026
Nami Surgical · finance.yahoo.com · Jan 28, 2026
Chemify · finsmes.com · Oct 22, 2025
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2022
LLP designated member · since 2018
LLP member · since 2020
LLP member · since 2019
LLP member · since 2019
Andrew Paul Mcneill — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Eos Advisory made?
- Eos Advisory has 25 tracked investments, including 6 dated in the last 24 months.
- What stage does Eos Advisory invest at?
- Eos Advisory invests at the Seed, Series A, Growth stages.
- What sectors does Eos Advisory focus on?
- Eos Advisory focuses on AgTech, Biotech, Cleantech, Climate Tech, Deep Tech, Digital Health, Energy, FoodTech, Healthtech, Impact & Social Good, IoT, Medical Devices.
- Where is Eos Advisory located?
- Eos Advisory is headquartered in St Andrews, GB.
- Does Eos Advisory lead rounds?
- Eos Advisory typically participates in rounds rather than leading them.
- Who does Eos Advisory co-invest with?
- Eos Advisory most often shares deals with Alba Equity, Future Planet Capital, UK Innovation & Science Seed Fund, among 24 tracked co-investors.
Media · Podcasts & interviews
featuring the teamSimilar investors
This page is the analysis and research library of BDC (Business Development Bank of Canada), listing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses and the venture capital landscape.
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.
Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.